Patent details
EP2004183
Title:
MAZINDOL COMBINATION IN THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY.
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
EP2004183
WO Application Number:
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP07727980.0
WO Publication Number:
EPO Publication Language:
French
SPC Number:
First Applicant Residence Country:
France (FR)
Publications:
Dates
Filing date:
11/04/2007
Grant date:
26/06/2013
EP Publication Date:
26/06/2013
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
26/06/2013
EP B1 Publication Date:
26/06/2013
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
25/09/2013
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
10/04/2027
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
27/10/2017
Name:
NLS-1 Pharma AG
Address:
Alter Postplatz 2, 6370, STANS, Switzerland (CH)
Historical Applicant/holder
From:
26/06/2013
To:
27/10/2017
Name:
Assistance Publique - Hôpitaux de Paris
Address:
3 Avenue Victoria, 75004 PARIS, France (FR)
Domicile Holder
Name:
ir. F.A. Geurts c.s.
From:
26/06/2013
Address:
Octrooibureau Vriesendorp & Gaade B.V.
Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:
Inventor
Name:
KONOFAL, Eric
Address:
60300 SENLIS, France (FR)
Priority
Priority Patent Number:
0603197
Priority Date:
11/04/2006
Priority Country:
France (FR)
Classification
Main IPC Class:
A61K 45/06 ;
Publication
Bulletin
1
Bulletin Heading:
CO
Journal edition number:
49/17
Publication date:
06/12/2017
Description:
Changes in the Netherlands Patent Register
2
Bulletin Heading:
EP3
Journal edition number:
2013/44
Publication date:
30/10/2013
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
3
Bulletin Heading:
EP2
Journal edition number:
2013/27
Publication date:
03/07/2013
Description:
European patents granted for the Netherlands
European Patent Bulletin
Issue number:
201326
Publication date:
26/06/2013
Description:
Grant (B1)
Deed
Change of owner(s)
Change Kind/ Decision Type:
Assignment
Deed Number:
RC201702113A
Date Registered:
27/10/2017
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
Name:
NLS-1 Pharma AG
Address:
Alter Postplatz 2, 6370, STANS, Switzerland (CH)
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Annual Fee
Annual Fee(s) Due Date:
30/04/2026
Annual Fee Number:
20
Annual Fee Amount:
1400 Euro
Last Annual Payment Date:
29/10/2025
Last Annual Fee Paid Number:
19
Last Annual Fee Paid Amount:
1300 Euro
Payer:
Acumass
Filing date
Document type
Document Description
Number of pages
File Type
05/12/2017
Outgoing Correspondence
Letter registration deed
1
PDF
/0/8/9/7/2/0507727980/docs/ep07727980.0_0_178802l118.pdf
27/10/2017
Request for Change
First filed deed
7
PDF
/0/8/9/7/2/0507727980/docs/ep07727980.0_6_rfc20171030034033749.pdf
24/10/2013
Outgoing Correspondence
Outgoing Letter
1
PDF
/0/8/9/7/2/0507727980/docs/ep07727980.0_5_outgoingcorrespondence20131024.pdf
25/09/2013
Incoming Correspondence Paper
Accompanying letter incoming document
2
PDF
/0/8/9/7/2/0507727980/docs/ep07727980.0_1_incomingcorrespondencepaper20130925.pdf
25/09/2013
Description
Translated description
17
PDF
/0/8/9/7/2/0507727980/docs/ep07727980.0_2_description20130925.pdf
25/09/2013
Claims
Translated claims
2
PDF
/0/8/9/7/2/0507727980/docs/ep07727980.0_3_claims20130925.pdf
25/09/2013
Outgoing Correspondence
Outgoing Letter
1
PDF
/0/8/9/7/2/0507727980/docs/ep07727980.0_4_outgoingcorrespondence20130925.pdf